Tyler Miller

Background

About Tyler Miller

Motivated by a deep-seated desire to make a positive impact on the world, I've spent the last 16 years focused on cancer research. My current work at Case Western Reserve University School of Medicine is dedicated to advancing immunotherapy treatments for brain tumors. As a physician-scientist, I combine my clinical expertise in molecular pathology with scientific expertise in cancer biology, genomics, and technology development to try to create innovative therapeutic strategies that significantly enhance the effectiveness of treatments. My scientific journey began in 2006 at The Ohio State University, where my undergraduate research identified some of the first microRNAs linked to cancer treatment resistance. This work was followed by significant discoveries during my medical and graduate studies at CWRU and Cleveland Clinic, where I developed novel in vivo assays for glioblastoma target discovery and discovered a number of new potential therapeutic targets for brain tumors. In 2018, I moved to Massachusetts General Hospital for a Clinical Pathology residency and to continue my research. After witnessing the limitations of targeted molecular therapies in clinical settings due to tumor heterogeneity, I pivoted his focus towards immunotherapy, convinced that engaging the immune system is the key to overcoming these challenges. During my residency and postdoctoral tenure at MGH and Dana Farber Cancer Institute, I advanced single-cell RNA sequencing technologies and our understanding of immunosuppressive myeloid cells in brain tumors. My current research leverages cutting-edge genomic technologies and novel ex vivo organoid models to further understand and manipulate myeloid cell states within tumors, aiming to transform these cells from tumor enablers to potent anti-cancer agents. Beyond my scientific endeavors, I am dedicated to broadening access to advanced medical treatments through my Advisory role with Care Access. Here, I champion efforts to expand clinical trial access to underrepresented communities, striving to enhance diversity in clinical research and reduce health disparities. This work is part of my broader vision to ensure that cutting-edge therapies are within reach for all patients, regardless of their background or location. Outside the laboratory, I enjoy boating on Lake Erie and partaking in the vibrant food, arts, and sports scenes of Cleveland with my wife of 14 years and our two young kids.